Income Statement

		Q3 2020-21	Q2 2020-21	Q1 2020-21	Q4 2019-20	Q3 2019-20	Q2 2019-20
	<	For the quarter ended Dec 31, 2020 US$'000	For the quarter ended Sep 30, 2020 US$'000	For the quarter ended Jun 30, 2020 US$'000	For the quarter ended Mar 31, 2020 US$'000	For the quarter ended Dec 31, 2019 US$'000	For the quarter ended Sep 30, 2019 US$'000	>
Revenue		17,245,443	14,518,909	13,347,856	10,579,371	14,102,836	13,521,989
Cost of sales		(14,459,338)	(12,266,356)	(11,306,548)	(8,717,632)	(11,838,210)	(11,339,441)
Gross Profit		2,786,105	2,252,553	2,041,308	1,861,739	2,264,626	2,182,548
Selling and distribution expenses		(863,021)	(726,174)	(632,167)	(614,866)	(816,261)	(777,804)
Administrative expenses		(859,267)	(643,215)	(661,102)	(720,412)	(609,157)	(584,534)
Research and development expenses		(398,102)	(306,532)	(332,570)	(347,169)	(341,232)	(318,028)
Other operating (expense)/income - net		35,492	(12,128)	20,408	(13,205)	(9,863)	(60,438)
Operating profit		701,207	564,505	435,877	166,087	488,113	441,744
Finance income		7,240	9,342	7,991	10,007	13,369	10,602
Finance costs		(109,923)	(91,617)	(106,832)	(95,359)	(107,595)	(136,218)
Share of gains of associated companies		(7,046)	(11,843)	(4,960)	(3,437)	(3,658)	(6,072)
Profit before taxation		591,478	470,387	332,076	77,298	390,228	310,056
Taxation		(160,043)	(120,833)	(85,269)	(13,875)	(84,729)	(66,417)
Profit for the period		431,434	349,554	246,807	63,423	305,499	243,639
Profit/(loss) attributable to:
Equity holders of the Company		395,062	310,195	212,822	42,553	258,117	202,194
Perpetual securities holders		5,652	13,440	13,440	13,440	13,440	13,440
Other non-controlling interests		30,720	25,919	20,545	7,430	33,942	28,005
		431,434	349,554	246,807	63,423	305,499	243,639
Earnings/(loss) per share attributable to equity holders of the Company
Basic (US cents)		3.31	2.59	2	0.36	2.16	1.69
Diluted (US cents)		3.08	2.48	2	0.35	2.07	1.62